The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27876250 |
60 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH |
Jagiellonian University Medical College |
27842797 |
42 |
NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids. |
University of Regensburg |
26824643 |
69 |
Mimicking of Arginine by Functionalized N(¿)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples. |
University of Regensburg |
26988801 |
55 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents. |
Jagiellonian University Medical College |
26348111 |
32 |
Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin Analogues. |
University of Montpellier |
24997685 |
39 |
The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1). |
The Scripps Research Institute |
25313322 |
62 |
Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists. |
Novartis Institutes For Biomedical Research |
24332089 |
35 |
Imidazole-derived agonists for the neurotensin 1 receptor. |
Sanford-Burnham Medical Research Institute |
24160350 |
4 |
Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors. |
Friedrich-Alexander University |
24611085 |
101 |
Discovery of ML314, a Brain Penetrant Non-Peptidic?-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor. |
Sanford-Burnham Medical Research Institute |
23582449 |
20 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor. |
Institute of Organic Synthesis |
23466604 |
36 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds. |
Universit£ |
20684563 |
176 |
Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential. |
H. Lundbeck |
18809332 |
8 |
Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1. |
Friedrich-Alexander University |
16854083 |
11 |
Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc. |
National Center For Scientific Research Demokritos |
15481995 |
6 |
Evaluation of lactam-bridged neurotensin analogues adjusting psi(Pro10) close to the experimentally derived bioactive conformation of NT(8-13). |
Friedrich-Alexander University |
12954066 |
63 |
In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues. |
Medical University of South Carolina |
12852770 |
28 |
Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors. |
Washington University |
21446649 |
78 |
Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics. |
Friedrich-Alexander University |
20813948 |
63 |
Spiroindolones, a potent compound class for the treatment of malaria. |
Swiss Tropical and Public Health Institute |
20591666 |
66 |
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase. |
Università |
20481538 |
4 |
Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic. |
Medical University of South Carolina Campus |
20452768 |
3 |
Synthesis of neurotensin(8-13)-phosphopeptide heterodimers via click chemistry. |
Institute of Radiopharmacy |
18849166 |
7 |
The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach. |
Wyeth Research |
19290594 |
64 |
Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy. |
Medical University of South Carolina |
19236044 |
4 |
Synthesis and applications of polyamine amino acid residues: improving the bioactivity of an analgesic neuropeptide, neurotensin. |
University of Utah |
19195889 |
8 |
The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay. |
Research Triangle Institute |
10743946 |
7 |
Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities. |
Medical University of South Carolina |
31390201 |
47 |
Discovery of ?-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators. |
Sanford Burnham Prebys Medical Discovery Institute |
31158752 |
6 |
Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor. |
University of Nebraska Medical Center |
32184966 |
13 |
An Alkyne-functionalized Arginine for Solid-Phase Synthesis Enabling "Bioorthogonal" Peptide Conjugation. |
University of Regensburg |
31938457 |
40 |
Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity. |
University of Regensburg |
31223455 |
12 |
Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS |
University of Regensburg |
29541365 |
15 |
In Search of the Optimal Macrocyclization Site for Neurotensin. |
Universit£ |
30035538 |
69 |
Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13). |
Universit£ |
29631962 |
252 |
Identification and biological evaluation of thiazole-based inverse agonists of ROR?t. |
Phenex Pharmaceuticals |
28368584 |
16 |
Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues. |
University of Montpellier |
17005826 |
27 |
Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads. |
University of Connecticut At Storrs |